Amphastar Pharmaceuticals Inc (AMPH) Implied Volatility Current

Tracking AMPH implied volatility helps you identify when options premiums on Amphastar Pharmaceuticals Inc are historically cheap or expensive, and where the best trades are hiding. Amphastar Pharmaceuticals Inc implied volatility reflects the market's expectation of future price movement: when AMPH IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Amphastar Pharmaceuticals Inc's implied volatility current levels in real time and filter for high-probability trades.

Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For AMPH, tracking metrics like AMPH IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on AMPH signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency.

The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block. Further, the company distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where AMPH implied volatility sits today versus where it has been. Our scanner ranks Amphastar Pharmaceuticals Inc implied volatility against its historical range, surfaces extremes in AMPH IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Amphastar Pharmaceuticals Inc IV is rich or cheap — measure it, then act on it.